# Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol

Study · id `cardio:ct-nct02403349` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02403349](<https://clinicaltrials.gov/study/NCT02403349>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02403349

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 105 participants.

## Technical summary

Registry record NCT02403349. Randomized; quadruple masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2015-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT02403349, source copy `cardio:ctgov-nct02403349-2015-03-31`, retrieved 2026-10-26)
- Start date: 2012-05 (registry gives no type) (ClinicalTrials.gov record NCT02403349, source copy `cardio:ctgov-nct02403349-2015-03-31`, retrieved 2026-10-26)
- Primary completion: 2015-05 (anticipated) (ClinicalTrials.gov record NCT02403349, source copy `cardio:ctgov-nct02403349-2015-03-31`, retrieved 2026-10-26)
- Completion: 2015-09 (anticipated) (ClinicalTrials.gov record NCT02403349, source copy `cardio:ctgov-nct02403349-2015-03-31`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02403349-2015-03-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. Atenolol
- Acronym: FAVOR
- Condition: Blood Pressure
- Condition: Ischemic Stroke
- Intervention (Drug): Fimasartan
- Intervention (Drug): Valsartan
- Intervention (Drug): Atenolol
- Lead sponsor: Ajou University School of Medicine
- Lead sponsor class: OTHER
- Collaborator: Boryung Pharmaceutical Co., Ltd
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Valsartan (`cardio:valsartan`)
- Registry intervention name matches this record: Atenolol (`cardio:atenolol`)
- Registry lists this organization as the lead sponsor: Ajou University School of Medicine (`cardio:org-ajou-university-school-of-medicine`)
- Registry lists this organization as a collaborator: Boryung Pharmaceutical Co., Ltd (`cardio:org-boryung-pharmaceutical-co-ltd`)

## Provenance

Content hash: 61059c18cd14c7774df9ea92677a97c19ecd4ca71198bdb723924308432fb8ab
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
